The Study of the Effects of Nanoparticles on Human Cells
A special issue of Nanomaterials (ISSN 2079-4991). This special issue belongs to the section "Biology and Medicines".
Deadline for manuscript submissions: 15 October 2024 | Viewed by 97
Special Issue Editors
Interests: drug delivery; nanomedicine; nanoparticles
Special Issues, Collections and Topics in MDPI journals
Interests: polymeric nanoparticles; nanomedicine; pharmaceutical technology; lipid nanoparticles; nanoprecipitation; nanoparticles loading poorly soluble drugs; drug delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nanotechnology is a branch of science concerned with the design, fabrication, and application of nanoparticles (NPs) and nanomaterials. Introduced by Feynman in 1959, the fields of nanoscience and nanotechnology have been subjected to growing interest from scientists in almost all research areas. They have not only been integrated into chemistry, engineering, agriculture, biology, and materials science, but have also been used to produce nanostructured medical devices and nanotherapeutics. As a result of this interest, NPs began to be commercialised in the early 2000s and exposed to popular opinion, facing both praise and criticism from the public. Indeed, despite the extent of documented research, there is still a gap in knowledge regarding the risk to human health consequent to exposure to NPs.
In this Special Issue of Nanomaterials, we welcome original research articles and reviews regarding nanoparticle applications and their effects on human cells. Particularly, articles should focus on the harmful effects of (a) inorganic-based NPs, (b) carbon-based NPs, (c) organic NPs, including lipid, polymer, and hybrids, (d) nanomaterials, and (e) engineered NPs on human cells. Further potential research areas include (but are not limited to) the following:
- drug delivery;
- medical therapies and diagnosis;
- biology and biotechnologies;
- agriculture and food industry;
- industrial processes;
- renewable energies;
- engineering and bio-engineering.
All contributions related to underlying cell viability and cytotoxicity, mechanisms of toxicology, and related evaluation models for analyzing NP risk effects are welcome.
We look forward to receiving your contributions.
Prof. Dr. Paolo Giunchedi
Dr. Carla Serri
Guest Editors
Dr. Sara Demartis
Guest Editor Assistant
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nanomaterials is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanoparticles
- nanomaterials
- nanotoxicology
- cytotoxicity
- immunotoxicity
- genotoxicity
- carcinogenesis
- oxidative stress
- inflammation
